Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp -TGM
Discovery Immunology · 01.01.2023 · 2 (1)
DOI: 10.1093/discim/kyad001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discovery Immunology, online erschienen am 18.01.2023. Verfasst von Danielle J Smyth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Centre for Integrative Parasitology, School of Infection and Immunity, University of Glasgow, Glasgow, UK. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Kenneth Rainin Foundation, Synergy and Innovator.
Abstract (Originalsprache)
In animal models of inflammatory colitis, pathology can be ameliorated by several intestinal helminth parasites, including the mouse nematode Heligmosomoides polygyrus. To identify parasite products that may exert anti-inflammatory effects in vivo, we tested H. polygyrus excretory–secretory (HES) products, as well as a recombinantly expressed parasite protein, transforming growth factor mimic (TGM), that functionally mimics the mammalian immunomodulatory cytokine TGF-β. HES and TGM showed a degree of protection in dextran sodium sulphate-induced colitis, with a reduction in inflammatory cytokines, but did not fully block the development of pathology. HES also showed little benefit in a similar acute trinitrobenzene sulphonic acid-induced model. However, in a T cell transfer-mediated model with recombination activation gene (RAG)-deficient mice, HES-reduced disease scores if administered throughout the first 2 or 4 weeks following transfer but was less effective if treatment was delayed until 14 days after T cell transfer. Recombinant TGM similarly dampened colitis in RAG-deficient recipients of effector T cells, and was effective even if introduced only once symptoms had begun to be manifest. These results are a promising indication that TGM may replicate, and even surpass, the modulatory properties of native parasite HES.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wellcome Centre for Integrative Parasitology, School of Infection and Immunity, University of Glasgow, Glasgow, UK.
- Division of Cell Signalling and Immunology, University of Dundee, Dundee, UK.
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Marta Campillo Poveda, Henry J McSorley, Rick M Maizels
Förderung
- Wellcome Trust
- Kenneth Rainin Foundation
- Synergy and Innovator
- Wellcome Centre for Integrative Parasitology
Zitieren
APA
Smyth, D. J., White, M. P. J., Johnston, C. J. C., Donachie, A. M., Campillo Poveda, M., McSorley, H. J., & Maizels, R. M. (2023). Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp -TGM. Discovery Immunology, 2(1). https://doi.org/10.1093/discim/kyad001
Vancouver
Smyth DJ, White MPJ, Johnston CJC, Donachie AM, Campillo Poveda M, McSorley HJ, et al. Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp -TGM. Discovery Immunology. 2023;2(1). doi:10.1093/discim/kyad001
BibTeX
@article{Smyth2023,
author = {Smyth, Danielle J and White, Madeleine P J and Johnston, Chris J C and Donachie, Anne-Marie and Campillo Poveda, Marta and McSorley, Henry J and Maizels, Rick M},
title = {Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp -TGM},
journal = {Discovery Immunology},
year = {2023},
volume = {2},
number = {1},
doi = {10.1093/discim/kyad001}
}
EUVIMED